Thrombectomy Devices Market by Thrombectomy Devices Technology (Mechanical, Aspiration, Rheolytic), Devices Type (Automated, Manual), Utility (Reusable Devices and Disposable Devices) and Diseases (Peripheral, Coronary and Neural) - Opportunity Analysis and Industry Forecast, 2014 - 2022

September 2016 | 118 pages | ID: TBE4F750CD4EN
Allied Market Research

Abstracts

Thrombectomy is the surgical removal of blood clot from a blood vessel. Venous thromboembolism (VTE) is a common lethal disease where blood clots within a vein. These clots can travel to arteries or veins in different parts of the body-brain, heart, kidneys, lungs, and limbs. VTE is considered as the cause of heart attack, stroke; however, it can also damage to the body’s organs or even death. VTE results due to various factors, which include combination of hereditary and acquired risk factors, obesity and post-surgery especially hip, knee, or pelvic surgery. It can be found in smoking population and people who take estrogens or birth control pills. VTE is most common in adults (>60 years) but can occur at any age.
The world thrombectomy devices market is estimated to garner $1,389 million by 2022. This is attributed by the increase in the incidence of acute myocardial infraction, peripheral arterial diseases, deep vein thrombosis, and pulmonary embolism due to the sedentary lifestyle, and unhealthy living conditions and habits in the current generation; rise in the geriatric population. The increase in incidence of cardiovascular diseases; growth in demand for minimally-invasive procedures, and demand for better healthcare infrastructure; and increase in competition, has led to technological advancements and innovations. However, lack of trained professionals and awareness, and complicated use of these devices restrict the market growth. In addition, deep vein thrombosis and pulmonary embolism sometimes remain underdiagnosed and can lead to serious health conditions, which can only be avoided by avoiding sedentary lifestyle and creating awareness among all.
The world thrombectomy devices market is segmented into five categories-technology, type, utility, disease, and geography. Based on the type of technology, the market is categorized into mechanical thrombectomy devices, aspiration thrombectomy devices, rheolytic thrombectomy devices. Based on type, the market is divided into automated devices and manual devices. Based on utility, the market is classified into reusable devices and disposable devices. The thrombectomy devices market is segmented into three disease categories, which include peripheral diseases, coronary diseases, and neuro diseases. Based on geography, the market is segmented into North America, Europe, Asia-Pacific, and LAMEA.
The growth in competition and continuous technological advancements have led to mergers & acquisitions by major players in the thrombectomy devices market. On September 2015, Medtronic acquired Lazarus Effect to strengthen its market of clot removal devices effective during ischemic stroke. Boston Scientific completed the acquisition of interventional business of Bayer AG on May 2014. This made Boston Scientific the leading innovator for peripheral vascular disease in the industry, and expanded their product portfolio and sales force across various geographies.

KEY MARKET BENEFITS:

• The quantitative analysis of the current trends and future estimations from 2014 to 2022 is provided to identify the prevailing opportunities and formulate growth strategies.
• In-depth analysis of the market based on geography gives an understanding of the regional market, which assists in strategic business planning.
• A detailed analysis based on technology is presented to understand the type of products in trend or would be in demand to assist in product developments and collaborations.
• Comprehensive analysis of the market drivers and constraints is provided to identify the prevailing market opportunities.
• Competitive intelligence highlights the business practices followed by leading market players across various geographies.

KEY MARKET SEGMENTS:

The world thrombectomy devices market segmentation is illustrated as follows:
By Technology

• Mechanical Thrombectomy Devices
• Aspiration Thrombectomy Devices
• Rheolytic Thrombectomy Devices

By Type

• Automated Devices
• Manual Devices

By Utility

• Reusable Devices
• Disposable Devices

By Diseases

• Peripheral Diseases
• Coronary Diseases
• Neural Diseases

By Geography

• North America
• U.S.
• Canada
• Mexico
• Europe
• U.K.
• Germany
• France
• Spain
• Italy
• Others
• Asia-Pacific
• China
• Japan
• India
• Others
• LAMEA
• Brazil
• Saudi Arabia
• South Africa
• Others

Company profiles

• Boston Scientific Corporation
• Medtronic Plc
• Teleflex Incorporated
• Penumbra Inc.
• The Spectranetics Corporation
• AngioDynamics, Inc.
• Terumo Corporation
• Johnson and Johnson, Inc.
• Stryker Corporation
• Vascular Solutions, Inc.

Contents

CHAPTER 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
  1.4.1 Secondary research
  1.4.2 Primary research
  1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO perspective

CHAPTER 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings
  3.2.1 Top investment pockets
  3.2.2 Top winning strategies
3.3 Porters five forces analysis
  3.3.1 Low bargaining power of suppliers
  3.3.2 Moderate bargaining power of buyers
  3.3.3 Moderate threat of new entrants
  3.3.4 Moderate threat of substitutes
  3.3.5 High competitive rivalry
3.4 Market dynamics
  3.4.1 Drivers
    3.4.1.1 High prevalence of PAD, AMI, DVT & PE conditions
    3.4.1.2 Rise in geriatric population
    3.4.1.3 Growing demand of minimally invasive procedures
    3.4.1.4 Better healthcare infrastructure
    3.4.1.5 High competiton among key players
  3.4.2 Restraints
    3.4.2.1 Lack of trained professionals and awareness
    3.4.2.2 High cost and complicated use of thrombectomy devices
  3.4.3 Opportunities
    3.4.3.1 Introductin of lasers and uv radiation, and 3D imaging generation in thrombectomy devices
    3.4.3.2 Combination of decompressive surgery and thrombectomy

CHAPTER 4 WORLD THROMBECTOMY DEVICES MARKET, BY TECHNOLOGY, 2014-2022

4.1 Overview
  4.1.1 Market size and forecast
4.2 Mechanical thrombectomy devices
  4.2.1 Key market trends
  4.2.2 Key growth factors and opportunities
  4.2.3 Market size and forecast
4.3 Aspiration thrombectomy devices
  4.3.1 Key market trends
  4.3.2 Key growth factors and opportunities
  4.3.3 Market size and forecast
4.4 Rheolytic thrombectomy devices
  4.4.1 Key market trends
  4.4.2 Key growth factors and opportunities
  4.4.3 Market size and forecast

CHAPTER 5 WORLD THROMBECTOMY DEVICES MARKET, BY TYPE, 2014-2022

5.1 Overview
  5.1.1 Market size and forecast
5.2 Automated devices
  5.2.1 Key market trends
  5.2.2 Key growth factors and opportunities
  5.2.3 Market size and forecast
5.3 Manual devices
  5.3.1 Key market trends
  5.3.2 Key growth factors and opportunities
  5.3.3 Market size and forecast

CHAPTER 6 WORLD THROMBECTOMY DEVICES MARKET, BY UTILITY, 2014-2022

6.1 Overview
  6.1.1 Market size and forecast
6.2 Reusable devices
  6.2.1 Key market trends
  6.2.2 Key growth factors and opportunities
  6.2.3 Market size and forecast
6.3 Disposable devices
  6.3.1 Key market trends
  6.3.2 Key growth factors and opportunities
  6.3.3 Market size and forecast

CHAPTER 7 WORLD THROMBECTOMY DEVICES MARKET, BY DISEASES, 2014-2022

7.1 Overview
  7.1.1 Market size and forecast
7.2 Peripheral Diseases
  7.2.1 Key market trends
  7.2.2 Key growth factors and opportunities
  7.2.3 Market size and forecast
7.3 Coronary Diseases
  7.3.1 Key market trends
  7.3.2 Key growth factors and opportunities
  7.3.3 Market size and forecast
7.4 Neural Diseases
  7.4.1 Key market trends
  7.4.2 Key growth factors and opportunities
  7.4.3 Market size and forecast

CHAPTER 8 WORLD THROMBECTOMY DEVICES MARKET, BY GEOGRAPHY, 2014-2022

8.1 Overview
  8.1.1 Market size and forecast
8.2 North America
  8.2.1 Key market trends
  8.2.2 Key growth factors and opportunities
  8.2.3 Market size and forecast
    8.2.3.1 U.S. Market size and forecast
    8.2.3.2 Canada Market size and forecast
    8.2.3.3 Mexcio Market size and forecast
8.3 Europe
  8.3.1 Key market trends
  8.3.2 Key growth factors and opportunities
  8.3.3 Market size and forecast
    8.3.3.1 Germany Market Size And Forecast
    8.3.3.2 France Market Size And Forecast
    8.3.3.3 U.K. Market Size And Forecast
    8.3.3.4 Italy Market Size And Forecast
    8.3.3.5 Spain Market Size And Forecast
    8.3.3.6 Rest Of Europe Market Size And Forecast
8.4 Asia-Pacific
  8.4.1 Key market trends
  8.4.2 Key growth factors and opportunities
  8.4.3 Market size and forecast
    8.4.3.1 Japan Market size and forecast
    8.4.3.2 China Market size and forecast
    8.4.3.3 India Market size and forecast
    8.4.3.4 Rest of Asia-Pacific Market size and forecast
8.5 Latin America, Middle East, Africa (LAMEA)
  8.5.1 Key market trends
  8.5.2 Key growth factors and opportunities
  8.5.3 Market size and forecast
    8.5.3.1 Brazil Market size and forecast
    8.5.3.2 Saudi Arabia Market size and forecast
    8.5.3.3 South Africa Market size and forecast
    8.5.3.4 Rest of lamea Market size and forecast

CHAPTER 9 COMPANY PROFILES

9.1 Boston Scientific Corporation
  9.1.1 Company overview
  9.1.2 Company snapshot
  9.1.3 Operating business segments
  9.1.4 Business performance
  9.1.5 Key strategic moves & developments
9.2 Medtronic Plc
  9.2.1 Company overview
  9.2.2 Company snapshot
  9.2.3 Operating business segments
  9.2.4 Business performance
  9.2.5 Key strategic moves & developments
9.3 Teleflex Incorporated
  9.3.1 Company overview
  9.3.2 Company snapshot
  9.3.3 Operating business segments
  9.3.4 Business performance
  9.3.5 Key strategic moves & developments
9.4 Terumo Corporation
  9.4.1 Company overview
  9.4.2 Company snapshot
  9.4.3 Operating business segments
  9.4.4 Business performance
  9.4.5 Key strategic moves & developments
9.5 Penumbra, Inc.
  9.5.1 Company overview
  9.5.2 Company snapshot
  9.5.3 Operating business segments
  9.5.4 Business performance
  9.5.5 Key strategic moves & developments
9.6 The Spectranetics Corporation
  9.6.1 Company overview
  9.6.2 Company snapshot
  9.6.3 Operating business segments
  9.6.4 Business performance
  9.6.5 Key strategic moves & developments
9.7 AngioDynamics, Inc.
  9.7.1 Company overview
  9.7.2 Company snapshot
  9.7.3 Operating business segments
  9.7.4 Business performance
  9.7.5 Key strategic moves & developments
9.8 Vascular Solutions, Inc.
  9.8.1 Company overview
  9.8.2 Company snapshot
  9.8.3 Operating business segments
  9.8.4 Business performance
  9.8.5 Key strategic moves & developments
9.9 Johnson & Johnson, Inc.
  9.9.1 Company overview
  9.9.2 Company snapshot
  9.9.3 Operating business segments
  9.9.4 Business performance
  9.9.5 Key strategic moves & developments
9.10 Stryker Corporation
  9.10.1 Company Overview
  9.10.2 Company Snapshot
  9.10.3 Operating business segments
  9.10.4 Business performance
  9.10.5 Key strategic moves & developments

List Of Tables

LIST OF TABLES

TABLE 1 WORLD THROMBECTOMY DEVICES MARKET, BY TECHNOLOGY, 20142022 ($MILLION)
TABLE 2 WORLD MECHANICAL THROMBECTOMY DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 3 WORLD ASPIRATION THROMBECTOMY MARKET, BY REGION, 20142022 ($MILLION)
TABLE 4 WORLD RHEOLYTIC THROMBECTOMY DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 5 WORLD THROMBECTOMY DEVICES MARKET, BY TYPE, 2014 2022 ($MILLION)
TABLE 6 WORLD AUTOMATED THROMBECTOMY DEVICES MARKET, BY REGION, 2014 2022 ($MILLION)
TABLE 7 WORLD MANUAL THROMBECTOMY DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 8 WORLD THROMBECTOMY DEVICES MARKET, BY UTILITY, 20142022 ($MILLION)
TABLE 9 WORLD REUSABLE THROMBECTOMY DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 10 WORLD DISPOSABLE THROMBECTOMY DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 11 WORLD THROMBECTOMY DEVICES MARKET, BY DISEASES, 20142022 ($MILLION)
TABLE 12 WORLD THROMBECTOMY DEVICES MARKET FOR PERIPHERAL DISEASES, BY REGION, 20142022 ($MILLION)
TABLE 13 WORLD THROMBECTOMY DEVICES MARKET FOR CORONARY DISEASES, BY REGION, 20142022 ($MILLION)
TABLE 14 WORLD THROMBECTOMY DEVICES MARKET FOR NEURAL DISEASES, BY REGION, 20142022 ($MILLION)
TABLE 15 WORLD THROMBECTOMY DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 16 NORTH AMERICA THROMBECTOMY DEVICES MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 17 NORTH AMERICA THROMBECTOMY DEVICES MARKET, BY TECHNOLGY, 20142022 ($MILLION)
TABLE 18 NORTH AMERICA THROMBECTOMY DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 19 NORTH AMERICA THROMBECTOMY DEVICES MARKET, BY UTILITY, 20142022 ($MILLION)
TABLE 20 NORTH AMERICA THROMBECTOMY DEVICES MARKET, BY DISEASES, 20142022 ($MILLION)
TABLE 21 EUROPE THROMBECTOMY DEVICES MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 22 EUROPE THROMBECTOMY DEVICES MARKET, BY TECHNOLGY, 20142022 ($MILLION)
TABLE 23 EUROPE THROMBECTOMY DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 24 EUROPE THROMBECTOMY DEVICES MARKET, BY UTILITY, 20142022 ($MILLION)
TABLE 25 EUROPE THROMBECTOMY DEVICES MARKET, BY DISEASES, 20142022 ($MILLION)
TABLE 26 ASIA-PACIFIC THROMBECTOMY DEVICES MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 27 ASIA-PACIFIC THROMBECTOMY DEVICES MARKET, BY TECHNOLGY, 20142022 ($MILLION)
TABLE 28 ASIA-PACIFIC THROMBECTOMY DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 29 ASIA-PACIFIC THROMBECTOMY DEVICES MARKET, BY UTILITY, 20142022 ($MILLION)
TABLE 30 ASIA-PACIFIC THROMBECTOMY DEVICES MARKET, BY DISEASES, 20142022 ($MILLION)
TABLE 31 LAMEA THROMBECTOMY DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 32 LAMEA THROMBECTOMY DEVICES MARKET, BY TECHNOLGY, 20142022 ($MILLION)
TABLE 33 LAMEA THROMBECTOMY DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 34 LAMEA THROMBECTOMY DEVICES MARKET, BY UTILITY, 20142022 ($MILLION)
TABLE 35 LAMEA THROMBECTOMY DEVICES MARKET, BY DISEASES, 20142022 ($MILLION)
TABLE 36 BOSTON - COMPANY SNAPSHOT
TABLE 37 BOSTON OPERATING SEGMENTS
TABLE 38 MEDTRONIC - COMPANY SNAPSHOT
TABLE 39 MEDTRONIC OPERATING SEGMENTS
TABLE 40 TELEFLEX - COMPANY SNAPSHOT
TABLE 41 TELEFLEX - OPERATING SEGMENTS
TABLE 42 TERUMO - COMPANY SNAPSHOT
TABLE 43 TERUMO - OPERATING SEGMENTS
TABLE 44 PENUMBRA - COMPANY SNAPSHOT
TABLE 45 PENUMBRA - OPERATING SEGMENTS
TABLE 46 SPECTRANETICS - COMPANY SNAPSHOT
TABLE 47 SPECTRANETICS - OPERATING SEGMENTS
TABLE 48 ANGIODYNAMICS - COMPANY SNAPSHOT
TABLE 49 ANGIODYNAMICS - OPERATING SEGMENTS
TABLE 50 VASC. SOL. - COMPANY SNAPSHOT
TABLE 51 VASCULAR SOLUTIONS - OPERATING SEGMENTS
TABLE 52 J&J - COMPANY SNAPSHOT
TABLE 53 J&J - OPERATING SEGMENTS
TABLE 54 STRYKER - COMPANY SNAPSHOT
TABLE 55 STRYKER - OPERATING SEGMENTS

List Of Figures

LIST OF FIGURES

FIG. 1 WORLD THROMBECTOMY DEVICES MARKET, BY TECHNOLOGY, 2015 VS 2022, ($MILLION)
FIG. 2 WORLD MORTALITY RATE (PER 100,000 POPULATION), 2000 VS 2012
FIG. 3 TOP INVESTMENT POCKETS IN WORLD THROMBECTOMY DEVICES MARKET
FIG. 4 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2012 2016)
FIG. 5 TOP WINNING STRATEGIES: TYPE
FIG. 6 PORTERS FIVE FORCES ANALYSIS
FIG. 7 TOP IMPACTING FACTORS
FIG. 8 PREVALENCE OF PERIPHERAL ARTERIAL DISEASE (PAD) BY AGE
FIG. 9 U.S. THROMBECTOMY DEVICES MARKET, 20142022 ($MILLION)
FIG. 10 CANADA THROMBECTOMY DEVICES MARKET, 20142022 ($MILLION)
FIG. 11 MEXCIO THROMBECTOMY DEVICES MARKET, 20142022 ($MILLION)
FIG. 12 GERMANY THROMBECTOMY DEVICES MARKET, 20142022 ($MILLION)
FIG. 13 FRANCE THROMBECTOMY DEVICES MARKET, 20142022 ($MILLION)
FIG. 14 U.K. THROMBECTOMY DEVICES MARKET, 20142022 ($MILLION)
FIG. 15 ITALY THROMBECTOMY DEVICES MARKET, 20142022 ($MILLION)
FIG. 16 SPAIN THROMBECTOMY DEVICES MARKET, 20142022 ($MILLION)
FIG. 17 OTHERS THROMBECTOMY DEVICES MARKET, 20142022 ($MILLION)
FIG. 18 JAPAN THROMBECTOMY DEVICES MARKET, 20142022 ($MILLION)
FIG. 19 CHINA THROMBECTOMY DEVICES MARKET, 20142022 ($MILLION)
FIG. 20 INDIA THROMBECTOMY DEVICES MARKET, 20142022 ($MILLION)
FIG. 21 OTHERS THROMBECTOMY DEVICES MARKET, 20142022 ($MILLION)
FIG. 22 BRAZIL THROMBECTOMY DEVICES MARKET, 20142022 ($MILLION)
FIG. 23 SAUDI ARABIA THROMBECTOMY DEVICES MARKET, 20142022 ($MILLION)
FIG. 24 SOUTH AFRICA THROMBECTOMY DEVICES MARKET, 20142022 ($MILLION)
FIG. 25 OTHERS THROMBECTOMY DEVICES MARKET, 20142022 ($MILLION)
FIG. 26 BOSTON: REVENUE BY YEAR ($MILLION)
FIG. 27 BOSTON: REVENUE BY SEGMENT, 2015 (%)
FIG. 28 BOSTON: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 29 MEDTRONIC: REVENUE BY YEAR ($MILLION)
FIG. 30 MEDTRONIC: REVENUE BY SEGMENT, 2016 (%)
FIG. 31 MEDTRONIC: REVENUE BY GEOGRAPHY, 2016 (%)
FIG. 32 TELEFLEX: REVENUE BY YEAR ($MILLION)
FIG. 33 TELEFLEX: REVENUE BY SEGMENT, 2015 (%)
FIG. 34 TERUMO: REVENUE BY YEAR ($MILLION)
FIG. 35 TERUMO: REVENUE BY SEGMENT, 2015 (%)
FIG. 36 TERUMO: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 37 PENUMBRA: REVENUE BY YEAR ($MILLION)
FIG. 38 PENUMBRA: REVENUE BY SEGMENT, 2015 (%)
FIG. 39 PENUMBRA: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 40 SPECTRANETICS: REVENUE BY YEAR ($MILLION)
FIG. 41 SPECTRANETICS: REVENUE BY SEGMENT, 2015 (%)
FIG. 42 SPECTRANETICS: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 43 ANGIODYNAMICS: REVENUE BY YEAR ($MILLION)
FIG. 44 ANGIODYNAMICS: REVENUE BY SEGMENTS, 2016 (%)
FIG. 45 ANGIODYNAMICS: REVENUE BY GEOGRAPHY, 2016 (%)
FIG. 46 VASCULAR SOLUTIONS: REVENUE BY YEAR ($MILLION)
FIG. 47 VASCULAR SOLUTIONS: REVENUE BY SEGMENT, 2015 (%)
FIG. 48 VASCULAR SOLUTIONS: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 49 J&J: REVENUE BY YEAR ($MILLION)
FIG. 50 J&J: REVENUE BY SEGMENT, 2015 (%)
FIG. 51 J&J: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 52 STRYKER: REVENUE BY YEAR ($MILLION)
FIG. 53 STRYKER: REVENUE BY SEGMENT, 2015 (%)
FIG. 54 STRYKER: REVENUE BY GEOGRAPHY, 2015 (%)